Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study.
Sivesh Kathir KamarajahSteven A WhiteSamer A NaffoujeGeorge I SaltiFadi DahdalehPublished in: Annals of surgical oncology (2021)
AC following NAC and resection is associated with improved survival, even in margin-negative and node-negative disease. These findings suggest completing planned systemic treatment should be considered in all resected PDACs previously treated with NAC.